Dow Up0.11% Nasdaq Up0.50%

Taro Pharmaceutical Industries Ltd. (TARO)

-NYSE
161.16 Up 0.43(0.27%) Aug 29, 4:02PM EDT
ProfileGet Profile for:
Taro Pharmaceutical Industries Ltd.
14 Hakitor Street
PO Box 10347
Haifa Bay, 2624761
Israel - Map
Phone: 972 4 847 5700
Website: http://www.taro.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Manufacturers - Other
Full Time Employees:1,342

Business Summary 

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets pharmaceutical products in the United States, Canada, Israel, and internationally. The company offers prescription and over-the-counter pharmaceutical products focusing on primary areas, including topical creams and ointments, liquids, capsules, and tablets in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. It also develops and manufactures active pharmaceutical ingredients for use in its finished dosage form products. The company sells and distributes its products to drug wholesalers and store chains, mass merchandisers, food and retail chains, managed care organizations, generic drug distributors, and others. Taro Pharmaceutical Industries Ltd. was founded in 1959 and is based in Haifa Bay, Israel.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Taro Pharmaceutical Industries Ltd.

Key Executives 
 PayExercised
Mr. Kalyanasundaram Subramanian , 60
Chief Exec. Officer and Director
N/AN/A
Mr. Michael Kalb CPA, 43
Interim Chief Financial Officer, Chief Accounting officer, VP and Chief Financial Officer of Taro Pharmaceuticals U S A Inc, Group
N/AN/A
Mr. Itzik Baruch , 51
VP of Technical Services
N/AN/A
Mr. Stephen Manzano Esq., 50
VP of Corp. Compliance and Interim Gen. Counsel
N/AN/A
Mr. Jayesh Shah , 58
Head of Procurement - USA
N/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders